Literature DB >> 12425480

Significant genetic linkage of MDR1 polymorphisms at positions 3435 and 2677: functional relevance to pharmacokinetics of digoxin.

Masanori Horinouchi1, Toshiyuki Sakaeda, Tsutomu Nakamura, Yoshinori Morita, Takao Tamura, Nobuo Aoyama, Masato Kasuga, Katsuhiko Okumura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12425480     DOI： 10.1023/a:1020433422259

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  15 in total

Review 1.  Biochemical, cellular, and pharmacological aspects of the multidrug transporter.

Authors:  S V Ambudkar; S Dey; C A Hrycyna; M Ramachandra; I Pastan; M M Gottesman
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

2.  Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues.

Authors:  F Thiebaut; T Tsuruo; H Hamada; M M Gottesman; I Pastan; M C Willingham
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

3.  Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects.

Authors:  I Cascorbi; T Gerloff; A Johne; C Meisel; S Hoffmeyer; M Schwab; E Schaeffeler; M Eichelbaum; U Brinkmann; I Roots
Journal:  Clin Pharmacol Ther       Date:  2001-03       Impact factor: 6.875

4.  No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.

Authors:  N von Ahsen; M Richter; C Grupp; B Ringe; M Oellerich; V W Armstrong
Journal:  Clin Chem       Date:  2001-06       Impact factor: 8.327

5.  Polymorphism of the ABC transporter genes, MDR1, MRP1 and MRP2/cMOAT, in healthy Japanese subjects.

Authors:  S Ito; I Ieiri; M Tanabe; A Suzuki; S Higuchi; K Otsubo
Journal:  Pharmacogenetics       Date:  2001-03

6.  Genetic polymorphism in MDR-1: a tool for examining allelic expression in normal cells, unselected and drug-selected cell lines, and human tumors.

Authors:  L A Mickley; J S Lee; Z Weng; Z Zhan; M Alvarez; W Wilson; S E Bates; T Fojo
Journal:  Blood       Date:  1998-03-01       Impact factor: 22.113

7.  Effect of grapefruit juice on digoxin pharmacokinetics in humans.

Authors:  L Becquemont; C Verstuyft; R Kerb; U Brinkmann; M Lebot; P Jaillon; C Funck-Brentano
Journal:  Clin Pharmacol Ther       Date:  2001-10       Impact factor: 6.875

8.  MDR1 pharmacogenetics: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity.

Authors:  M M Ameyaw; F Regateiro; T Li; X Liu; M Tariq; A Mobarek; N Thornton; G O Folayan; J Githang'a; A Indalo; D Ofori-Adjei; D A Price-Evans; H L McLeod
Journal:  Pharmacogenetics       Date:  2001-04

9.  P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.

Authors:  N Kioka; J Tsubota; Y Kakehi; T Komano; M M Gottesman; I Pastan; K Ueda
Journal:  Biochem Biophys Res Commun       Date:  1989-07-14       Impact factor: 3.575

10.  Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.

Authors:  S Hoffmeyer; O Burk; O von Richter; H P Arnold; J Brockmöller; A Johne; I Cascorbi; T Gerloff; I Roots; M Eichelbaum; U Brinkmann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205
View more
  24 in total

1.  Prediction of systemic exposure to cyclosporine in Japanese pediatric patients.

Authors:  Toshiyuki Sakaeda; Kazumoto Iijima; Kandai Nozu; Tsutomu Nakamura; Yuka Moriya; Mika Nishikawa; Atsushi Wada; Noboru Okamura; Masafumi Matsuo; Katsuhiko Okumura
Journal:  J Hum Genet       Date:  2006-09-14       Impact factor: 3.172

2.  Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.

Authors:  Balram Chowbay; Huihua Li; Machin David; Yin Bun Cheung; Edmund J D Lee
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

Review 3.  Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.

Authors:  Mei-Ling Chen
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

4.  Influence of ABCB1 gene polymorphisms on the pharmacokinetics of verapamil among healthy Chinese Han ethnic subjects.

Authors:  Li-Mei Zhao; Xiao-Jing He; Feng Qiu; Ya-Xin Sun; Jesse Li-Ling
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

5.  Genetic variability and haplotype profile of MDR1 in Saudi Arabian males.

Authors:  Abdullah M Al-Mohizea; Khalid M Alkharfy; Khawla M Bagulb; Amal M Alghamdi; Fahad I Al-Jenoobi; Saleh Al-Muhsen; Rabih Halwani; Mohammad Khalid Parvez; M Khalid Parvez; Mohammed S Al-Dosari
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

6.  Influence of ABCB1 and ABCG2 polymorphisms on the antiemetic efficacy in patients with cancer receiving cisplatin-based chemotherapy: a TRIPLE pharmacogenomics study.

Authors:  D Tsuji; M Yokoi; K Suzuki; T Daimon; M Nakao; H Ayuhara; Y Kogure; K Shibata; T Hayashi; K Hirai; K Inoue; T Hama; K Takeda; M Nishio; K Itoh
Journal:  Pharmacogenomics J       Date:  2016-05-31       Impact factor: 3.550

7.  Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy.

Authors:  Mari Yokoi; Daiki Tsuji; Kenichi Suzuki; Yohei Kawasaki; Masahiko Nakao; Hideaki Ayuhara; Yuuki Kogure; Kazuhiko Shibata; Toshinobu Hayashi; Keita Hirai; Kazuyuki Inoue; Toshihiro Hama; Koji Takeda; Makoto Nishio; Kunihiko Itoh
Journal:  Support Care Cancer       Date:  2017-11-24       Impact factor: 3.603

Review 8.  Multidrug resistance 1 gene in inflammatory bowel disease: a meta-analysis.

Authors:  V Annese; M-R Valvano; O Palmieri; A Latiano; F Bossa; A Andriulli
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

9.  Effect of MDR1 C3435T polymorphism on lansoprazole in healthy Japanese subjects.

Authors:  Chise Kodaira; Mitsushige Sugimoto; Masafumi Nishino; Mihoko Yamade; Naohito Shirai; Shinya Uchida; Mutsuhiro Ikuma; Shizuo Yamada; Hiroshi Watanabe; Akira Hishida; Takahisa Furuta
Journal:  Eur J Clin Pharmacol       Date:  2009-02-24       Impact factor: 2.953

10.  MDR1 genotype-related duodenal absorption rate of digoxin in healthy Japanese subjects.

Authors:  Yoshinori Morita; Toshiyuki Sakaeda; Masanori Horinouchi; Tsutomu Nakamura; Kohei Kuroda; Ikuya Miki; Ken Yoshimura; Toshiyuki Sakai; Daisuke Shirasaka; Takao Tamura; Nobuo Aoyama; Masato Kasuga; Katsuhiko Okumura
Journal:  Pharm Res       Date:  2003-04       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.